Search results
- Dictionaryinvestigational/ɪnˌvɛstɪˈɡeɪʃən(ə)l/
adjective
- 1. denoting or concerned with investigation; investigative: "students are encouraged to adopt an active, investigational approach to their learning"
Powered by Oxford Dictionaries
20 hours ago · What are the phases of a clinical trial? Explore the definitions of phase 1, 2, 3 and 4 clinical trials and learn how to find a trial that fits your needs.
1 day ago · The relative rarity of haematological illness leads to our ultraspecialists. The doctors and scientists who can navigate the complexity of transplantation medicine, investigational therapeutics, and modern genetics are irreplaceable. They are the front face of haematology and bring investment, people, and success into the profession.
1 day ago · Background Aging leads to a decline in muscle mass and strength, contributing to frailty and decreased quality of life. Sirolimus (rapamycin) , an mTOR inhibitor, has shown potential in preclinical studies to extend lifespan and improve health span. This study evaluates the safety and efficacy of once-weekly sirolimus (rapamycin) administration on muscle strength and endurance in older adults ...
1 day ago · First, developers need to outline the key objectives of the IDE submission clearly. This lays the groundwork for assembling relevant information and securing necessary approvals. A well-defined objective helps in identifying the specific data that needs to be collected and analyzed, which ultimately streamlines the entire process.
20 hours ago · A Z-Score larger than −3 is defined as an indication of non-toxicity (light-grey dotted line). p = 0.0237 for MOI 1E6, p = 0.0002 for MOI 2E6, p < 0.0001 for MOI 4E6 – 16E6. ( C ) Representative images from ( A ) of SH-SY5Y cells treated with different multiplicity of infections (MOI) for 72 h.
20 hours ago · PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the first patient was dosed in the Phase 3 clinical trial of investigational drug UGN-103 (mitomycin) for intravesical solution in development for the treatment of low-grade ...
20 hours ago · The U.S. Food and Drug Administration (FDA) accepted the Investigational New Drug Application for UGN-103 in April 2024, permitting the drug’s investigational use in adults with LG-IR-NMIBC, a ...
